{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:30:27Z","timestamp":1791419427632,"version":"4.3.3"},"reference-count":128,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T00:00:00Z","timestamp":1662595200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p>Antimicrobial resistance has become one of the greatest threats to human health, and new antibacterial treatments are urgently needed. As a tool to develop novel therapies, animal models are essential to bridge the gap between preclinical and clinical research. However, despite common usage of <jats:italic>in vivo<\/jats:italic> models that mimic clinical infection, translational challenges remain high. Standardization of <jats:italic>in vivo<\/jats:italic> models is deemed necessary to improve the robustness and reproducibility of preclinical studies and thus translational research. The European Innovative Medicines Initiative (IMI)-funded \u201cCollaboration for prevention and treatment of MDR bacterial infections\u201d (COMBINE) consortium, aims to develop a standardized, quality-controlled murine pneumonia model for preclinical efficacy testing of novel anti-infective candidates and to improve tools for the translation of preclinical data to the clinic. In this review of murine pneumonia model data published in the last 10 years, we present our findings of considerable variability in the protocols employed for testing the efficacy of antimicrobial compounds using this <jats:italic>in vivo<\/jats:italic> model. Based on specific inclusion criteria, fifty-three studies focusing on antimicrobial assessment against <jats:italic>Pseudomonas aeruginosa, Klebsiella pneumoniae<\/jats:italic> and <jats:italic>Acinetobacter baumannii<\/jats:italic> were reviewed in detail. The data revealed marked differences in the experimental design of the murine pneumonia models employed in the literature. Notably, several differences were observed in variables that are expected to impact the obtained results, such as the immune status of the animals, the age, infection route and sample processing, highlighting the necessity of a standardized model.<\/jats:p>","DOI":"10.3389\/fmicb.2022.988728","type":"journal-article","created":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T09:59:57Z","timestamp":1662631197000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":28,"title":["Variability of murine bacterial pneumonia models used to evaluate antimicrobial agents"],"prefix":"10.3389","volume":"13","author":[{"given":"Rakel","family":"Arrazuria","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Kerscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen E.","family":"Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Hoover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carina Vingsbo","family":"Lundberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon Ulf","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Sordello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephane","family":"Renard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Aranzana-Climent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diarmaid","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Gribbon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena E.","family":"Friberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Bekeredjian-Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S0924-8579(02)00022-5","article-title":"Animal model pharmacokinetics and pharmacodynamics: A critical review.","volume":"19","author":"Andes","year":"2002","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B2","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.coph.2017.09.004","article-title":"In vivo infection models in the pre-clinical pharmacokinetic\/pharmacodynamic evaluation of antimicrobial agents.","volume":"36","author":"Andes","year":"2017","journal-title":"Curr. Opin. Pharmacol."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00948-18","article-title":"Assessment of the in vivo efficacy of WCK 5222 (Cefepime-Zidebactam) against carbapenem-resistant Acinetobacter baumannii in the neutropenic murine lung infection model.","volume":"62","author":"Avery","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"B4","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1161\/CIRCRESAHA.114.303819","article-title":"Reproducibility in science: Improving the standard for basic and preclinical research.","volume":"116","author":"Begley","year":"2015","journal-title":"Circ. Res."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01755","article-title":"Challenges for clinical development of vaccines for prevention of hospital-acquired bacterial infections.","volume":"11","author":"Bekeredjian-Ding","year":"2020","journal-title":"Front. Immunol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1128\/AAC.01269-15","article-title":"Pharmacodynamics of ceftazidime and avibactam in neutropenic mice with thigh or lung infection.","volume":"60","author":"Berkhout","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"B7","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/164_2019_279","article-title":"Blinding and randomization.","volume":"257","author":"Bespalov","year":"2020","journal-title":"Handb. Exp. Pharmacol."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.21037\/atm.2017.03.72","article-title":"Animal models of hospital-acquired pneumonia: Current practices and future perspectives.","volume":"5","author":"Bielen","year":"2017","journal-title":"Ann. Transl. Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.1128\/AAC.04110-14","article-title":"Assessment of minocycline and polymyxin B combination against Acinetobacter baumannii.","volume":"59","author":"Bowers","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"B10","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1099\/jmm.0.47848-0","article-title":"Growth-phase regulation of lipopolysaccharide O-antigen chain length influences serum resistance in serovars of Salmonella.","volume":"57","author":"Bravo","year":"2008","journal-title":"J. Med. Microbiol."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/srep26077","article-title":"In vitro and in vivo efficacy, toxicity, bio-distribution and resistance selection of a novel antibacterial drug candidate.","volume":"6","author":"Brunetti","year":"2016","journal-title":"Sci. Rep."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00115-16","article-title":"Pharmacokinetic-pharmacodynamic evaluation of gepotidacin against gram-positive organisms using data from murine infection models.","volume":"61","author":"Bulik","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02307-18","article-title":"Generating robust and informative nonclinical in vitro and in vivo bacterial infection model efficacy data to support translation to humans.","volume":"63","author":"Bulitta","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"B14","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.bbi.2016.08.002","article-title":"Age and sex differences in immune response following LPS treatment in mice.","volume":"58","author":"Cai","year":"2016","journal-title":"Brain Behav. Immun."},{"key":"B15","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1099\/mic.0.2007\/010066-0","article-title":"O-antigen modal chain length in Shigella flexneri 2a is growth-regulated through RfaH-mediated transcriptional control of the wzy gene.","volume":"153","author":"Carter","year":"2007","journal-title":"Microbiology"},{"key":"B16","doi-asserted-by":"publisher","first-page":"3291","DOI":"10.1093\/jac\/dkv267","article-title":"New pharmacokinetic\/pharmacodynamic studies of systemically administered colistin against Pseudomonas aeruginosa and Acinetobacter baumannii in mouse thigh and lung infection models: Smaller response in lung infection.","volume":"70","author":"Cheah","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"B17","doi-asserted-by":"publisher","first-page":"547.e1","DOI":"10.1016\/j.cmi.2017.08.029","article-title":"Enhanced efficacy of the engineered antimicrobial peptide WLBU2 via direct airway delivery in a murine model of Pseudomonas aeruginosa pneumonia.","volume":"24","author":"Chen","year":"2018","journal-title":"Clin. Microbiol. Infect."},{"key":"B18","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s10059-011-2322-6","article-title":"Growth phase-differential quorum sensing regulation of anthranilate metabolism in Pseudomonas aeruginosa.","volume":"32","author":"Choi","year":"2011","journal-title":"Mol. Cells"},{"key":"B19","doi-asserted-by":"publisher","first-page":"4991","DOI":"10.1128\/AAC.00390-16","article-title":"Efficacy of the novel antibiotic POL7001 in preclinical models of Pseudomonas aeruginosa pneumonia.","volume":"60","author":"Cigana","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02456-2018","article-title":"Antibiotic efficacy varies based on the infection model and treatment regimen for Pseudomonas aeruginosa.","volume":"55","author":"Cigana","year":"2020","journal-title":"Eur. Respir. J."},{"key":"B21","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/978-3-642-80364-2_7","article-title":"Pharmacodynamics of fluoroquinolones in experimental animals","author":"Craig","year":"1998","journal-title":"Quinolone antibacterials. handbook of experimental pharmacology"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00764-17","article-title":"Treatment with atorvastatin provides additional benefits to imipenem in a model of gram-negative pneumonia induced by Klebsiella pneumoniae in mice.","volume":"62","author":"de Paula","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/0895-4356(94)00230-N","article-title":"Gender differences in cystic fibrosis: Pseudomonas aeruginosa infection.","volume":"48","author":"Demko","year":"1995","journal-title":"J. Clin. Epidemiol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.nhtm.2014.08.001","article-title":"Animal models in translational medicine: Validation and prediction.","volume":"2","author":"Denayer","year":"2014","journal-title":"New Horiz. Transl. Med."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0188251","article-title":"Spectrum of pathogen- and model-specific histopathologies in mouse models of acute pneumonia.","volume":"12","author":"Dietert","year":"2017","journal-title":"PLoS One"},{"key":"B26","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.ijantimicag.2011.10.012","article-title":"Efficacies of colistin and tigecycline in mice with experimental pneumonia due to NDM-1-producing strains of Klebsiella pneumoniae and Escherichia coli.","volume":"39","author":"Docobo-P\u00e9rez","year":"2012","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B27","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/nrmicro862","article-title":"Antimicrobial pharmacodynamics: Critical interactions of \u201cbug and drug.\u201d.","volume":"2","author":"Drusano","year":"2004","journal-title":"Nat. Rev. Microbiol."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01323-17","article-title":"Dilution factor of quantitative bacterial cultures obtained by bronchoalveolar lavage in patients with ventilator-associated bacterial pneumonia.","volume":"62","author":"Drusano","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"B29","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s00335-021-09863-7","article-title":"The gut microbiome of laboratory mice: Considerations and best practices for translational research.","volume":"32","author":"Ericsson","year":"2021","journal-title":"Mamm. Genome"},{"key":"B30","year":"2016","journal-title":"Guideline on the use of pharmacokinetics and pharmacodynamics in the development of antimicrobial medicinal products."},{"key":"B31","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1093\/ilar\/ilu036","article-title":"Evidence should trump intuition by preferring inbred strains to outbred stocks in preclinical research.","volume":"55","author":"Festing","year":"2014","journal-title":"ILAR J."},{"key":"B32","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1177\/0023677217738268","article-title":"On determining sample size in experiments involving laboratory animals.","volume":"52","author":"Festing","year":"2018","journal-title":"Lab. Anim."},{"key":"B33","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1002\/cpt.2182","article-title":"Pivotal role of translation in anti-infective development.","volume":"109","author":"Friberg","year":"2021","journal-title":"Clin. Pharmacol. Ther."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/928290","article-title":"Role of sex steroid hormones in bacterial-host interactions.","volume":"2013","author":"Garc\u00eda-G\u00f3mez","year":"2013","journal-title":"Biomed Res. Int."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1093\/jac\/dky058","article-title":"Morpholino oligomers tested in vitro, in biofilm and in vivo against multidrug-resistant Klebsiella pneumoniae.","volume":"73","author":"Geller","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"B36","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/S0167-5699(98)01330-9","article-title":"B-cell development: A comparison between mouse and man.","volume":"19","author":"Ghia","year":"1998","journal-title":"Immunol. Today"},{"key":"B37","doi-asserted-by":"publisher","first-page":"O831","DOI":"10.1111\/1469-0691.12677","article-title":"In vitro and in vivo activities of piperacillin-tazobactam and meropenem at different inoculum sizes of ESBL-producing Klebsiella pneumoniae.","volume":"20","author":"Harada","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"key":"B38","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.ijantimicag.2013.07.009","article-title":"Pharmacokinetics and efficacy of liposomal polymyxin B in a murine pneumonia model.","volume":"42","author":"He","year":"2013","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B39","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/978-1-4939-0467-9_17","article-title":"Pharmacokinetics and pharmacodynamics of antibiotics in biofilm infections of Pseudomonas aeruginosa in vitro and in vivo.","volume":"1147","author":"Hengzhuang","year":"2014","journal-title":"Methods Mol. Biol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1093\/infdis\/jis766","article-title":"Assessment of antimicrobial combinations for Klebsiella pneumoniae carbapenemase-producing K. pneumoniae.","volume":"207","author":"Hirsch","year":"2013","journal-title":"J. Infect. Dis."},{"key":"B41","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1289\/ehp.00108s3463","article-title":"Development of the murine and human immune system: Differential effects of immunotoxicants depend on time of exposure.","volume":"108","author":"Holladay","year":"2000","journal-title":"Environ. Health Perspect."},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001482","article-title":"Progress in using systematic reviews of animal studies to improve translational research.","volume":"10","author":"Hooijmans","year":"2013","journal-title":"PLoS Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"162","DOI":"10.3109\/03009734.2014.896437","article-title":"Discovery and preclinical development of new antibiotics.","volume":"119","author":"Hughes","year":"2014","journal-title":"Ups. J. Med. Sci."},{"key":"B44","doi-asserted-by":"publisher","first-page":"s15","DOI":"10.1126\/scitranslmed.3004631","article-title":"Extrapolating from animals to humans.","volume":"4","author":"Ioannidis","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1177\/0023677216653984","article-title":"Does age matter? The impact of rodent age on study outcomes.","volume":"51","author":"Jackson","year":"2017","journal-title":"Lab. Anim."},{"key":"B46","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1093\/jac\/dks343","article-title":"Efficacy of ceftolozane in a murine model of Pseudomonas aeruginosa acute pneumonia: In vivo antimicrobial activity and impact on host inflammatory response.","volume":"68","author":"Jacqueline","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00180-20","article-title":"Pharmacodynamics of cefepime combined with the novel extended-spectrum-lactamase (ESBL) inhibitor enmetazobactam for murine pneumonia caused by ESBLproducing Klebsiella pneumonia.","volume":"64","author":"Johnson","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00828-17","article-title":"Efficacy and pharmacokinetics of the combination of OP0595 and cefepime in a mouse model of pneumonia caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae.","volume":"61","author":"Kaku","year":"","journal-title":"Antimicrob. Agents Chemother."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1093\/jac\/dkw517","article-title":"Efficacy and pharmacokinetics of ME1100, a novel optimized formulation of arbekacin for inhalation, compared with amikacin in a murine model of ventilator-associated pneumonia caused by Pseudomonas aeruginosa.","volume":"72","author":"Kaku","year":"","journal-title":"J. Antimicrob. Chemother."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1111\/j.1476-5381.2010.00872.x","article-title":"Animal research: Reporting in vivo experiments: The ARRIVE guidelines.","volume":"160","author":"Kilkenny","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02341-18","article-title":"Efficacy of aerosolized rifaximin versus tobramycin for treatment of Pseudomonas aeruginosa pneumonia in mice.","volume":"63","author":"Kirby","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"B52","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1165\/rcmb.2013-0340OC","article-title":"Development of a novel preclinical model of pneumococcal pneumonia in nonhuman primates.","volume":"50","author":"Kraft","year":"2014","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-53714-0","article-title":"In vivo efficacy of combination of colistin with fosfomycin or minocycline in a mouse model of multidrug-resistant Acinetobacter baumannii pneumonia.","volume":"9","author":"Ku","year":"2019","journal-title":"Sci. Rep."},{"key":"B54","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1258\/la.2011.011087","article-title":"A step-by-step guide to systematically identify all relevant animal studies.","volume":"46","author":"Leenaars","year":"2012","journal-title":"Lab. Anim."},{"key":"B55","doi-asserted-by":"publisher","first-page":"4764","DOI":"10.1128\/AAC.00647-16","article-title":"In vivo pharmacodynamic target assessment of delafloxacin against Staphylococcus aureus, Streptococcus pneumoniae, and Klebsiella pneumoniae in a murine lung infection model.","volume":"60","author":"Lepak","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.apsb.2019.08.003","article-title":"Recent progress in drug delivery.","volume":"9","author":"Li","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"key":"B57","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1080\/10837450.2016.1228666","article-title":"Electrostatically entrapped colistin liposomes for the treatment of Pseudomonas aeruginosa infection.","volume":"22","author":"Li","year":"2017","journal-title":"Pharm. Dev. Technol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1159\/000479411","article-title":"Synergistic activity of berberine with azithromycin against Pseudomonas aeruginosa isolated from patients with cystic fibrosis of lung in vitro and vn vivo.","volume":"42","author":"Li","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1097\/ALN.0000000000000222","article-title":"A novel porcine model of ventilator-associated pneumonia caused by oropharyngeal challenge with Pseudomonas aeruginosa.","volume":"120","author":"Li Bassi","year":"2014","journal-title":"Anesthesiology"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00211-17","article-title":"Aerosolized polymyxin B for treatment of respiratory tract infections: Determination of pharmacokinetic-pharmacodynamic indices for aerosolized polymyxin B against Pseudomonas aeruginosa in a mouse lung infection model.","volume":"61","author":"Lin","year":"","journal-title":"Antimicrob. Agents Chemother."},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02025-16","article-title":"Pharmacokinetics\/pharmacodynamics of pulmonary delivery of colistin against Pseudomonas aeruginosa in a mouse lung infection model.","volume":"61","author":"Lin","year":"","journal-title":"Antimicrob. Agents Chemother."},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01790-17","article-title":"Elucidating the pharmacokinetics\/pharmacodynamics of aerosolized colistin against multidrug-resistant Acinetobacter baumannii and Klebsiella pneumoniae in a mouse lung infection model.","volume":"62","author":"Lin","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"B63","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.ijantimicag.2011.06.006","article-title":"Pre-clinical studies of a new quinolone (UB-8902) against Acinetobacter baumannii resistant to ciprofloxacin.","volume":"38","author":"L\u00f3pez-Rojas","year":"2011","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B64","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.actbio.2018.07.038","article-title":"Antimicrobial polymers as therapeutics for treatment of multidrug-resistant Klebsiella pneumoniae lung infection.","volume":"78","author":"Lou","year":"2018","journal-title":"Acta Biomater."},{"key":"B65","doi-asserted-by":"publisher","first-page":"2788","DOI":"10.1128\/AAC.02624-12","article-title":"Impact of meropenem in combination with tobramycin in a murine model of Pseudomonas aeruginosa pneumonia.","volume":"57","author":"Louie","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1093\/infdis\/jiu603","article-title":"Combination treatment with meropenem plus levofloxacin is synergistic against Pseudomonas aeruginosa infection in a murine model of pneumonia.","volume":"211","author":"Louie","year":"2015","journal-title":"J. Infect. Dis."},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0219824","article-title":"Natural history of Acinetobacter baumannii infection in mice.","volume":"14","author":"Luna","year":"2019","journal-title":"PLoS One"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-74503-0","article-title":"In vivo bactericidal effect of colistin\u2013linezolid combination in a murine model of MDR and XDR Acinetobacter baumannii pneumonia.","volume":"10","author":"Ma","year":"2020","journal-title":"Sci. Rep."},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1002\/advs.201901872","article-title":"Considerations and caveats in combating ESKAPE pathogens against nosocomial infections.","volume":"7","author":"Ma","year":"2020","journal-title":"Adv. Sci."},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2021.05.014","article-title":"Let\u2019s talk about sex: Differences in drug therapy in males and females.","volume":"175","author":"Madla","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.02994-19","article-title":"Vaccine protection against multidrug-resistant Klebsiella pneumoniae in a nonhuman primate model of severe lower respiratory tract infection.","volume":"10","author":"Malachowa","year":"2019","journal-title":"mBio"},{"key":"B72","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1007\/s00726-016-2266-4","article-title":"In vitro and in vivo evaluation of BMAP-derived peptides for the treatment of cystic fibrosis-related pulmonary infections.","volume":"48","author":"Mardirossian","year":"2016","journal-title":"Amino Acids"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003601","article-title":"Host adaptation is contingent upon the infection route taken by pathogens.","volume":"9","author":"Martins","year":"2013","journal-title":"PLoS Pathog."},{"key":"B74","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1165\/rcmb.2009-0210ST","article-title":"An official american thoracic society workshop report: Features and measurements of experimental acute lung injury in animals.","volume":"44","author":"Matute-Bello","year":"2011","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1038\/srep30201","article-title":"Efficacy of species-specific protein antibiotics in a murine model of acute Pseudomonas aeruginosa lung infection.","volume":"6","author":"McCaughey","year":"2016","journal-title":"Sci. Rep."},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.3389\/fragi.2022.859991","article-title":"Age-related intestinal dysbiosis and enrichment of gut-specific bacteria in the lung are associated with increased susceptibility to Streptococcus pneumoniae infection in mice.","volume":"3","author":"McMahan","year":"2022","journal-title":"Front. Aging"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01525-2019","article-title":"Can animal models really teach us anything about pneumonia? Con.","volume":"55","author":"Metersky","year":"2020","journal-title":"Eur. Respir. J."},{"key":"B78","first-page":"176","article-title":"Histopathologic evaluation of lung and extrapulmonary tissues show sex differences in Klebsiella pneumoniae - infected mice under different exposure conditions.","volume":"3","author":"Mikerov","year":"2011","journal-title":"Int. J. Physiol. Pathophysiol. Pharmacol."},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0031359","article-title":"Visualization of murine intranasal dosing efficiency using luminescent Francisella tularensis: Effect of instillation volume and form of anesthesia.","volume":"7","author":"Miller","year":"2012","journal-title":"PLoS One"},{"key":"B80","doi-asserted-by":"publisher","first-page":"L387","DOI":"10.1152\/ajplung.00330.2007","article-title":"Animal models of human pneumonia.","volume":"294","author":"Mizgerd","year":"2008","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1159\/000486445","article-title":"Humanized exposures of a \u03b2-Lactam-\u03b2-lactamase inhibitor, tazobactam, versus non-\u03b2-lactam-\u03b2-lactamase inhibitor, avibactam, with or without colistin, against Acinetobacter baumannii in murine thigh and lung infection models.","volume":"101","author":"Monogue","year":"2018","journal-title":"Pharmacology"},{"key":"B82","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.pop.2018.05.006","article-title":"Emergence of global antibiotic resistance.","volume":"45","author":"Morehead","year":"2018","journal-title":"Prim. Care"},{"key":"B83","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1111\/j.1699-0463.1997.tb05092.x","article-title":"Chronic Pseudomonas aeruginosa lung infection is more severe in Th2 responding BALB\/c mice compared to Th1 responding C3H\/HeN mice.","volume":"105","author":"Moser","year":"1997","journal-title":"Apmis"},{"key":"B84","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/s0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis.","volume":"399","author":"Murray","year":"2022","journal-title":"Lancet"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02031-18","article-title":"In vivo pharmacodynamic study of cefiderocol, a novel parenteral siderophore cephalosporin, in murine thigh and lung infection models.","volume":"63","author":"Nakamura","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02724-20","article-title":"Pseudomonas aeruginosa ventilator-associated pneumonia rabbit model for preclinical drug development.","volume":"65","author":"Nguyen","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"B87","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1126\/science.aab2374","article-title":"Promoting an open research culture.","volume":"348","author":"Nosek","year":"2015","journal-title":"Science"},{"key":"B88","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1126\/science.288.5469.1251","article-title":"High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection.","volume":"288","author":"Oliver","year":"2000","journal-title":"Science"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02056-16","article-title":"Efficacy of high-dose meropenem (six grams per day) in treatment of experimental murine pneumonia induced by meropenem-resistant Pseudomonas aeruginosa.","volume":"61","author":"Oshima","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"B90","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1007\/s10096-011-1173-6","article-title":"Efficacy of rifampin, in monotherapy and in combinations, in an experimental murine pneumonia model caused by panresistant Acinetobacter baumannii strains.","volume":"30","author":"Pach\u00f3n-Ib\u00e1\u00f1ez","year":"2011","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"B91","doi-asserted-by":"publisher","first-page":"4464","DOI":"10.1128\/AAC.02708-15","article-title":"Efficacy of lysophosphatidylcholine in combination with antimicrobial agents against Acinetobacter baumannii in experimental murine peritoneal sepsis and pneumonia models.","volume":"60","author":"Parra Mill\u00e1n","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"B92","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1097\/QCO.0000000000000627","article-title":"New treatment options for multiresistant gram negatives.","volume":"33","author":"Paterson","year":"2020","journal-title":"Curr. Opin. Infect. Dis."},{"key":"B93","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/nrd3849","article-title":"In search of preclinical robustness.","volume":"11","author":"Peers","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3000410","article-title":"The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research.","volume":"18","author":"Percie du Sert","year":"2020","journal-title":"PLoS Biol."},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1007\/s11357-015-9796-7","article-title":"Global gene expression profile of normal and regenerating liver in young and old mice.","volume":"37","author":"Pibiri","year":"2015","journal-title":"Age"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1172\/JCI.INSIGHT.132223","article-title":"Biological sex influences susceptibility to Acinetobacter baumannii pneumonia in mice.","volume":"5","author":"Pires","year":"2020","journal-title":"JCI Insight"},{"key":"B97","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1093\/infdis\/jiz341","article-title":"Combination of azithromycin and gentamicin for efficient ereatment of Pseudomonas aeruginosa infections.","volume":"220","author":"Ren","year":"2019","journal-title":"J. Infect. Dis."},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01745-16","article-title":"Classical \u03b2-lactamase inhibitors potentiate the activity of daptomycin against methicillin-resistant Staphylococcus aureus and colistin against Acinetobacter baumannii.","volume":"61","author":"Sakoulas","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"B99","doi-asserted-by":"publisher","first-page":"581","DOI":"10.2217\/fmb-2019-0022","article-title":"Colistin-glycopeptide combinations against multidrug-resistant Acinetobacter baumannii in a mouse model of pneumonia.","volume":"14","author":"Sanderink","year":"2019","journal-title":"Future Microbiol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1128\/IAI.73.1.532-545.2005","article-title":"Central role of toll-like receptor 4 signaling and host defense in experimental pneumonia caused by gram-negative bacteria.","volume":"73","author":"Schurr","year":"2005","journal-title":"Infect. Immun."},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-017-0277-3","article-title":"The development of lower respiratory tract microbiome in mice.","volume":"5","author":"Singh","year":"2017","journal-title":"Microbiome"},{"key":"B102","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1177\/0023677217724823","article-title":"PREPARE: Guidelines for planning animal research and testing.","volume":"52","author":"Smith","year":"2018","journal-title":"Lab. Anim."},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1111\/acel.12893","article-title":"Influenza virus inoculum volume is critical to elucidate age-dependent mortality in mice.","volume":"18","author":"Smith","year":"2019","journal-title":"Aging Cell"},{"key":"B104","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2165\/00003088-200948030-00001","article-title":"Sex differences in pharmacokinetics and pharmacodynamics.","volume":"48","author":"Soldin","year":"2009","journal-title":"Clin. Pharmacokinet."},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.03130","article-title":"Mouse models and tools for the in vivo study of neutrophils.","volume":"10","author":"Stackowicz","year":"2020","journal-title":"Front. Immunol."},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-76895-5","article-title":"Synergistic effect of chlorogenic acid and levofloxacin against Klebsiella pneumoniae infection in vitro and in vivo.","volume":"10","author":"Tan","year":"2020","journal-title":"Sci. Rep."},{"key":"B107","doi-asserted-by":"publisher","first-page":"e34","DOI":"10.1016\/j.ijid.2011.09.015","article-title":"Comparative evaluation of intratracheal colistimethate sodium, imipenem, and meropenem in BALB\/c mice with carbapenem-resistant Acinetobacter baumannii pneumonia.","volume":"16","author":"Tang","year":"2012","journal-title":"Int. J. Infect. Dis."},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.106008","article-title":"How preclinical infection models help define antibiotic doses in the clinic.","volume":"56","author":"T\u00e4ngd\u00e9n","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B109","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.ijantimicag.2016.08.012","article-title":"Pharmacodynamic and pharmacokinetic profiling of delafloxacin in a murine lung model against community-acquired respiratory tract pathogens.","volume":"48","author":"Thabit","year":"2016","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B110","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/s41579-019-0288-0","article-title":"The global preclinical antibacterial pipeline.","volume":"18","author":"Theuretzbacher","year":"2020","journal-title":"Nat. Rev. Microbiol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/s41592-018-0224-7","article-title":"Comparing phenotypic variation between inbred and outbred mice.","volume":"15","author":"Tuttle","year":"2018","journal-title":"Nat. Methods"},{"key":"B112","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF00918959","article-title":"Effect of irradiation, cyclophospahmide, and etoposide (VP-16) on number of peripheral blood and peritoneal leukocytes in mice under normal conditions and during acute inflammatory reaction.","volume":"13","author":"Van\u2019t Wout","year":"1989","journal-title":"Inflammation"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.01774-20","article-title":"Sex steroids induce membrane stress responses and virulence properties in Pseudomonas aeruginosa.","volume":"11","author":"Vidaillac","year":"2020","journal-title":"mBio"},{"key":"B114","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.1016\/S0264-410X(02)00247-5","article-title":"Tracking the tissue distribution of marker dye following intranasal delivery in mice and chinchillas: A multifactorial analysis of parameters affecting nasal retention.","volume":"20","author":"Visweswaraiah","year":"2002","journal-title":"Vaccine"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02242-19","article-title":"Assessing animal models of bacterial pneumonia used in investigational new drug applications for the treatment of bacterial pneumonia.","volume":"64","author":"Waack","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"B116","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1128\/AAC.06486-11","article-title":"In vivo pharmacokinetics\/pharmacodynamics of colistin and imipenem in Pseudomonas aeruginosa biofilm infection.","volume":"56","author":"Wang","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"B117","first-page":"1","year":"2017","journal-title":"Global Priority List of Antibiotic-Resistant Bacteria to Guide Research, Discovery, and Development of New Antibiotics."},{"key":"B118","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1007\/s10156-011-0359-2","article-title":"In vivo efficacy and pharmacokinetics of biapenem in a murine model of ventilator-associated pneumonia with Pseudomonas aeruginosa.","volume":"18","author":"Yamada","year":"2012","journal-title":"J. Infect. Chemother."},{"key":"B119","doi-asserted-by":"publisher","first-page":"3883","DOI":"10.1128\/AAC.00457-13","article-title":"Azithromycin attenuates lung inflammation in a mouse model of ventilator-associated pneumonia by multidrug-resistant Acinetobacter baumannii.","volume":"57","author":"Yamada","year":"","journal-title":"Antimicrob. Agents Chemother."},{"key":"B120","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.ijantimicag.2013.05.016","article-title":"In vivo efficacy of biapenem with ME1071, a novel metallo-\u03b2-lactamase (MBL) inhibitor, in a murine model mimicking ventilator-associated pneumonia caused by MBL-producing Pseudomonas aeruginosa.","volume":"42","author":"Yamada","year":"","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B121","doi-asserted-by":"publisher","first-page":"4047","DOI":"10.1128\/AAC.02994-15","article-title":"In vivo and in vitro efficacy of minocycline-based combination therapy for minocycline-resistant Acinetobacter baumannii.","volume":"60","author":"Yang","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"B122","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.ijantimicag.2014.02.012","article-title":"Pharmacokinetic\/pharmacodynamic evaluation of sulbactam against Acinetobacter baumannii in in vitro and murine thigh and lung infection models.","volume":"43","author":"Yokoyama","year":"2014","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B123","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1128\/AAC.35.8.1527","article-title":"Animal models in the evaluation of antimicrobial agents.","volume":"35","author":"Zak","year":"1991","journal-title":"Antimicrob. Agents Chemother."},{"key":"B124","doi-asserted-by":"publisher","first-page":"6390","DOI":"10.1016\/j.bmc.2016.11.008","article-title":"Animal models in the pharmacokinetic\/pharmacodynamic evaluation of antimicrobial agents.","volume":"24","author":"Zhao","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01131-19","article-title":"In vivo pharmacodynamic target determination for delafloxacin against Klebsiella pneumoniae and Pseudomonas aeruginosa in the neutropenic murine pneumonia model.","volume":"63","author":"Zhao","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02371-16","article-title":"Pharmacokinetics and pharmacodynamics of minocycline against Acinetobacter baumannii in a neutropenic murine pneumonia model.","volume":"61","author":"Zhou","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02691-16","article-title":"In vivo pharmacokinetic and pharmacodynamic profiles of antofloxacin against Klebsiella pneumoniae in a neutropenic murine lung infection model.","volume":"61","author":"Zhou","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-6-55","article-title":"Neutropenia induced in outbred mice by a simplified low-dose cyclophosphamide regimen: Characterization and applicability to diverse experimental models of infectious diseases.","volume":"6","author":"Zuluaga","year":"2006","journal-title":"BMC Infect. Dis."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2022.988728\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T10:00:03Z","timestamp":1662631203000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2022.988728\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,8]]},"references-count":128,"alternative-id":["10.3389\/fmicb.2022.988728"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2022.988728","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,8]]},"article-number":"988728"}}